Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Pediatric Cardiology
Published in: Pediatric Cardiology 4/2006

01-08-2006 | LETTER TO THE EDITOR

What Do We Know about Endomyocardial Fibrosis in Children of Africa?

Authors: Eloi Marijon, Phalla Ou

Published in: Pediatric Cardiology | Issue 4/2006

Login to get access

Excerpt

Endomyocardial fibrosis is a restrictive cardiomyopathy of unknown etiology that occurs most commonly in tropical and subtropical areas, mainly in children and adolescents belonging to the poorest groups of the population [3]. It is characterized by an endocardial fibrotic thickening that predominates at the apex and inlet chamber of one or both ventricles. It is an endemic cause of heart disease in certain tropical areas, such as coastal regions of Mozambique, with a prevalence of up to 9% of the population. …
Literature
1.
Davies JNP (1948) Endomyocardial fibrosis. A heart disease of obscure etiology in Africans. East Afr Med J 25:10–14
2.
Freers J, Mayanja-Kizza H, Rutakingirwa M, Gerwing E (1996) Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema? Lancet 347:197PubMedCrossRef
3.
Rutakingirwa M, Ziegler JL, Newton R, Freers J (1999) Poverty and eosinophilia are risk factors for endomyocardial fibrosis in Uganda, Trop Med Int Health 3:229–235CrossRef
4.
Sezy CL (1996) Effects of cassava diet on Ceircopithecus aethiops livers: a case for cassava as the cause of both tropical splenomegaly syndrome (TSS) and endomyocardial fibrosis (EMF). East Afr Med J 73:S24–S28
5.
Urhoghide GE, Falase AO (1987) Degranulated eosinophils, eosinophil granule basic proteins and humoral factors in Nigerians with endomyocardial fibrosis. Afr J Med Med Sci 16:133–139PubMed
Metadata
Title
What Do We Know about Endomyocardial Fibrosis in Children of Africa?
Authors
Eloi Marijon
Phalla Ou
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 4/2006
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-006-1262-y

Other articles of this Issue 4/2006

Pediatric Cardiology 4/2006 Go to the issue

ORIGINAL ARTICLES

Cardiac Troponin T and Cardiac Dysfunction in Extremely Low-Birth-Weight Infants

OriginalPaper

Interventional Occlusion of a Thrombosed Aortic Conduit

OriginalPaper

Redirection of the Hepatic Venous Flow for the Treatment of Pulmonary Arteriovenous Malformations after Fontan Operation

OriginalPaper

Coexistence of Three Rare Congenital Heart Defects in a Single Patient

OriginalPaper

Catheter-Based Closure of an Atrial Septal Defect in Scimitar Syndrome

OriginalPaper

Aortic Root Dilatation is a Rare Complication of Noonan Syndrome

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits